DAAN Biotherapeutics
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $21M
Investors
- 14
About DAAN Biotherapeutics
Based in Seoul, South Korea, and founded in 2020, DAAN Biotherapeutics, Inc. operates as a biotechnology company dedicated to the development of treatments for cancer patients. In January 2024, DAAN Biotherapeutics, Inc., which engages in the development of cell therapy and antibody therapy for patients, specifically targets lung cancer by engineering T Cell Receptors (TCR) based on natural killer cells, specialized cells that have the ability to selectively and effectively target EGFR (Epidermal Growth Factor Receptor) mutations, a common characteristic of lung cancer. Additionally, DAAN Biotherapeutics, Inc. provides antibody therapeutics that target double or triple antibodies, inhibiting new targets discovered through single-cell transcriptome analysis of the tumor microenvironment.
Who invested in DAAN Biotherapeutics
14 investors across 2 rounds
See all investors in DAAN Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DAAN Biotherapeutics
Who invested in DAAN Biotherapeutics?
DAAN Biotherapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DAAN Biotherapeutics raised?
DAAN Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DAAN Biotherapeutics last raise money?
DAAN Biotherapeutics's most recent round on record is a Series A, in Jan 2024.
What does DAAN Biotherapeutics do?
Based in Seoul, South Korea, and founded in 2020, DAAN Biotherapeutics, Inc.
Where is DAAN Biotherapeutics headquartered?
DAAN Biotherapeutics is headquartered in Seoul, South Korea.
Which VCs invest in companies like DAAN Biotherapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at DAAN Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like DAAN Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.